Proteon Therapeutics

Infobox Company
name = Proteon Therapeutics
company_
type = Private
foundation =
industry = Pharmaceuticals
homepage = [http://www.proteontherapeutics.com/ www.proteontherapeutics.com]

Proteon Therapeutics, Inc. is a developer of pharmaceuticals with offices in Waltham, Massachusetts and Kansas City, Missouri.

It is developing PRT-201, a drug to improve blood flow following vascular surgery procedures, and, more broadly, is interested in vascular access for hemodialysis and peripheral arterial disease (PAD). On September 10, 2008, Proteon announced that the Food and Drug Administration had granted fast track status to PRT-201.

Proteon was founded by Dr. F. Nicholas Franano based on technology created at Johns Hopkins University. Major investors in the company include Rockhill Partners, TVM Capital, Skyline Ventures, Prism VentureWorks and Intersouth Partners. They have invested over $30 million in the company. [cite news |first=Rob |last=Roberts |authorlink= |coauthors= |title=Proteon secures $12M in financing |url=http://www.bizjournals.com/kansascity/stories/2007/04/02/daily30.html |work=Kansas City Business Journal |publisher= |date=Thursday, April 5, 2007 |accessdate=2008-07-27 ]

References

*cite news |first=Rob |last=Roberts |authorlink= |coauthors= |title=Proteon secures $12M in financing |url=http://www.bizjournals.com/kansascity/stories/2007/04/02/daily30.html |work=Kansas City Business Journal |publisher= |date=Thursday, April 5, 2007 |accessdate=2008-07-27
*cite news |first=Ryan |last=McBride |authorlink= |coauthors= |title=Proteon chief pulls the GelTex band back together |url=http://www.masshightech.com/stories/2008/04/07/newscolumn2-Proteon-chief-pulls-the-GelTex-band-back-together.html |work=MHT Mass High Tech |publisher= |date=Monday, April 7, 2008 |accessdate=2008-07-27

External links

* [http://www.proteontherapeutics.com Proteon Therapeutics, Inc.] Official site